Results · Apr-Jun 2026
Tejnaksh Healthcare Q1 FY27 results
Sales grew 1% to ₹2.7 crore from ₹2.6 crore in Apr-Jun 2025.
Operating profit grew 15% to ₹0.69 crore, an operating margin of 26.0% (up 3.2 points from a year ago).
Net profit grew 23% to ₹0.26 crore from ₹0.21 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +4%, net profit −25%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 2.7 | 2.6 | +1% |
| Operating profit (EBITDA) | 0.7 | 0.6 | +15% |
| Operating margin | 26.0% | 22.8% | +3.2 pts |
| Net profit | 0.3 | 0.2 | +23% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.